Alcoholic liver disease: Proposed recommendations for the American College of Gastroenterology

American Journal of Gastroenterology

Volumn 93, Issue 11, 1998, Pages 2022-2036

  McCullough, Arthur J ^a,b   O'Connor, J F Barry ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANABOLIC AGENT; BRANCHED CHAIN AMINO ACID; CASEIN; COLCHICINE; CORTICOSTEROID; GLUCAGON; INSULIN; MALOTILATE; OXANDROLONE; PROPYLTHIOURACIL; TESTOSTERONE;

ALCOHOL LIVER DISEASE; CLINICAL TRIAL; HUMAN; LABORATORY DIAGNOSIS; LIVER BIOPSY; LIVER TRANSPLANTATION; LONG TERM CARE; NUTRITION; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR;

HUMANS; LIVER DISEASES, ALCOHOLIC;

EID: 0032451389     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00587.x     Document Type: Review

References (206)

1. HCIA, Inc., Baltimore MD, 1995.
2. Grant B.F., DeBakey S., Zobeck T.S. Surveillance Report No. 18. Liver cirrhosis mortality in the United States, 1973-1988. 1991;National Institute on Alcohol Abuse and Alcoholism, Division of Biometry and Epidemiology, U.S. Department of Health and Human Services, Rockville, MD.
3. Propst A., Propst T., Zangerl G., et al. Prognosis and life expectancy in chronic liver disease. Dig Dis Sci. 40:1995;1805-1815.
4. Chedid A., Mendenhall C.L., Gartside P., et al. Prognostic factors in alcoholic liver disease. Am J Gastroenterol. 86:1991;210-216.
5. Pares A., Caballeria J., Bruguera M. Histological course of alcoholic hepatitis Influence of abstinence, sex, and extent of hepatic damage . J Hepatol. 2:1986;33-42.
6. Midanik L.J., Room R. The epidemiology of alcohol consumption. Alcohol Health Res World. 16:1992;183-190.
7. Gordis E. The etiology, consequences, and treatment of alcoholism. Liver Transplant Surgery. 3:1997;199-205.
8. Diagnostic and statistical manual of mental disorders (Ed 4). 1994;American Psychiatric Association, Washington, DC.
9. The ICD-10 classification of mental and behavioral disorders Clinical descriptions and diagnostic guidelines (Tenth Revision) . 1992;World Health Organization, Geneva.
10. Kitchens J.M. Does this patient have an alcohol problem? JAMA. 272:1994;1782-1787.
11. Lelbach W.K. Epidemiology of alcoholic liver disease. Popper H., Schaffner F. Progress in liver disease. vol 5:1976;494-515 Grune and Stratton, New York.
12. Sheth S.C., Gordon F.D., Chopra S. Non-alcoholic steatohepatitis. Ann Intern Med. 126:1997;137-145.
13. Umbricht-Schneiter A., Santora P., Moore R. Alcohol abuse Comparison of two methods for assessing its prevalence and associated morbidity in hospitalized patients . Am J Med. 91:1991;110-118.
14. Skinner H.A., Holt S., Schuller R. Identification of alcohol abuse using laboratory tests and history of trauma. Ann Intern Med. 101:1984;847-851.
15. Buchsbaum D., Buchanan R.G., Centor R.M., et al. Screening for alcohol abuse using CAGE scores and likelihood ratios. Ann Intern Med. 115:1991;774-777.
16. Girela E., Villaneuva E., Hernandez-Cueto C., et al. Comparison of the CAGE questionnaire versus some biochemical markers in the diagnosis of alcoholism. Alcohol Alcoholism. 29:1994;337-343.
17. Allen J.P., Maisto S.A., Connors G. Self-report screening tests for alcohol problems in primary care. Arch Intern Med. 155:1995;1726-1730.
18. Waterson E.J., Murray-Lyon I.M. Asking about alcohol A comparison of three methods used in an antenatal clinic . J Obstet Gynecol. 8:1988;303-306.
19. Bradley K. Interpreting CAGE scores. Ann Intern Med. 116:1992;1032. (letter).
20. Murray-Lyon I.M., Waterson E.J. CAGE. Lancet. 338:1993;1089-1090. (letter).
21. Steinweg D., Worth H. Alcoholism The keys to the CAGE . Am J Med. 94:1993;520-523.
22. Loft S., Olesen K.L., Dossing M. Increased susceptibility to liver disease in relation to alcohol consumption in women. Scand J Gastroenterol. 22:1976;1251-1256.
23. Morgan M.Y. Alcoholic liver disease Natural history, diagnosis, clinical features, evaluation, management, prognosis and prevention . McIntyre N., Benhamou J.P., Bircher J., et al. Oxford textbook of clinical Hepatology. 1991;815-855 Oxford University Press, Oxford, Eng.
24. Conn H.O., Atterbury C.E. Cirrhosis. Schiff L., Schiff E.R. Diseases of the liver. 1993;875-934 JP Lippincott, Philadelphia.
25. Dutta S.K., Dukehart M., Narang A., et al. Functional and structural changes in parotid glands of alcohol cirrhotic patients. Gastroenterology. 96:1989;510-518.
26. Attali P., Ink O., Pelletier G., et al. Dupuytren's contracture, alcohol consumption and chronic liver disease. Arch Intern Med. 147:1987;1065-1067.
27. Espinosa P., Ducot B., Pelletier G., et al. Interobserver agreement in the physical diagnosis of alcoholic liver disease. Dig Dis Sci. 32:1987;244-247.
28. Cattau E.L., Benjamin S.B., Knuff T.E., et al. The accuracy of the physical examination in the diagnosis of suspected ascites. JAMA. 247:1982;1164-1166.
29. Runyon B.A. Care of patients with ascites. N Eng J Med. 330:1994;337-342.
30. Moller S., Bendtsen F., Christensen E., et al. Prognostic variables in patients with cirrhosis and esophageal varices without prior bleeding. J Hepatology. 21:1994;940-946.
31. Foutch P.G., Sullivan J.A., Gaines J.A., et al. Cutaneous vascular spiders in cirrhotic patients Correlation with hemorrhage from esophageal varices . Am J Gastroenterol. 83:1988;723-726.
32. Zoli M., Magalotti D., Grimaldi M., et al. Physical examination of the liver Is it still worth it? Am J Gastroenterol. 90:1995;1428-1432.
33. Bell H., Tallaksen C., Try K., et al. Carbohydrate deficient transferrin and other markers of high alcohol consumption A study of 502 patients admitted consecutively to a medical department . Alcohol Clin Exp Res. 18:1994;1103-1108.
34. Cohen J., Kaplan M. The SGOT/SGPT ratio - an indicator of alcoholic liver disease. Dig Dis Sci. 24:1979;835-838.
35. Seeff L.B., Cuccherini B.A., Zimmerman H.J., et al. Acetaminophen hepatotoxicity in alcoholics. Ann Intern Med. 104:1986;399-404.
36. Yersin B., Nicolet J.F., Dercy H., et al. Screening for excessive alcohol drinking; comparative value of carbohydrate deficient transferrin, gamma glutamyl transferase and mean corpuscular volume. Arch Intern Med. 155:1995;1907-1911.
37. Stauber R.E., Stephan V., Trauner M., et al. Evaluation of carbohydrate deficient transferrin for detection of alcohol abuse in patients with liver dysfunction. Alcohol Alcoholism. 30:1995;171-176.
38. Goldberg S.J., Mendenhall C.L., Connell A.M., et al. "Nonalcoholic" chronic hepatitis in the alcoholic. Gastroenterology. 72:1977;598-604.
39. Piccinino F., Sagnelli E., Pasquale G., et al. Complications following percutaneous liver biopsy. A multicenter retrospective study on 68,276 biopsies. J Hepatol. 2:1986;165-173.
40. Garcia-Tsao G., Boyer J.L. Outpatient liver biopsy How safe is it? Ann Intern Med. 118:1993;150-153.
41. Bedossa P., Poynard T., Naveau S., et al. Observer variation in assessment of liver biopsies of alcoholic patient. Alcohol Clin Exp Res. 12:1988;1:173-1:177.
42. Van Ness M., Diehl A. Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Ann Intern Med. 111:1989;473-478.
43. Bird G. Can't treat, won't treat? Alcoholic liver disease. Br J Addict. 86:1991;695-700.
44. Rankin J.G., Orrego-Matte R., Deschenes J., et al. Alcoholic liver disease the problem of diagnosis . Alcohol Clin Exp Res. 2:1978;327-337.
45. Talley N.J., Roth A., Woods J., et al. Diagnostic value of liver biopsy in alcoholic liver disease. J Clin Gastroenterol. 10:1988;647-650.
46. Ryback R., Eckardt M.J., Felsher B., et al. Biochemical and hematological correlates of alcoholism and liver disease. JAMA. 248:1982;2261-2265.
47. Sanchez G.C., Baunsgaard P., Lundborg C.J. A comparison between clinical diagnosis and histopathological findings in liver biopsies. Scand J Gastroenterol. 15:1980;985-991.
48. Poynard T., Aubert A., Bedossa P., et al. A simple biological index for detection of alcoholic liver disease in drinkers. Gastroenterology. 100:1991;1397-1402.
49. Levin D.L., Baker A.L., Riddel R.H., et al. Non alcoholic liver disease. Overlooked causes of liver injury in patients with heavy alcohol consumption. Am J Med. 66:1979;429-434.
50. Nei J., Matsuda Y., Takada A. Chronic hepatitis induced by alcohol. Dig Dis Sci. 28:1983;207-215.
51. Takase S., Takada N., Enomoto N., et al. Different types of chronic hepatitis in alcoholic patients. Does chronic hepatitis induced by alcohol exist? Hepatology. 13:1991;876-881.
52. Kryger P., Schlichting P., Dietrichson O., et al. The accuracy of the clinical diagnosis in acute hepatitis and alcoholic liver disease. Scand J Gastroenterol. 18:1983;691-696.
53. Atterbury C. Should we routinely perform liver biopsy in suspected alcoholic liver disease? J Clin Gastroenterol. 10:1988;605-607.
54. Bell H., Skinningsrud A., Raknerud N., et al. Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver diseases. J Int Med. 236:1994;315-322.
55. Worner T.M., Lieber C.S. Perivenular fibrosis as precursor lesion of cirrhosis. JAMA. 254:1985;627-630.
56. Teli M.R., Day C.P., Burt A.D., et al. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet. 346:1995;987-990.
57. Kyriacou E., Simmonds P., Miller E.K., et al. Liver biopsy findings in patients with alcoholic liver disease complicated by chronic hepatitis C infection. Eur J Gastroenterol Hepatol. 7:1995;331-334.
58. Noguchi O., Yamaoka K., Ikeda T., et al. Clinicopathological analysis of alcoholic liver disease complicating chronic hepatitis C. Liver. 11:1991;225-230.
59. Imperiale T., McCullough A.J. Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials. Ann Intern Med. 113:1990;299-307.
60. Mathurin P. Interet de la biopsie hepatique pour la selection des sujets suspects d'hepatite alcoolique aigue. Journees francophones d'hepatologie et de patholigies digestives. Gastroenterol Clin Biol. 16:1992;A231.
61. Mathurin P., Duchatelle V., Ramond M.J., et al. Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology. 110:1996;1847-1853.
62. Chedid A., Mendenhall C.L., Tosch T., et al. Significance of megamitochondria in alcoholic liver disease. Gastroenterology. 90:1986;1858-1864.
63. Sawyerr A.M., McCormick P.A., Tennyson G.S., et al. A comparison of transjugular and plugged-percutaneous liver biopsy in patients with impaired coagulation. J Hepatol. 17:1993;81-85.
64. McAfee J.H., Keefe E.B., Lee R.G., et al. Transjugular liver biopsy. Hepatology. 15:1992;726-732.
65. Savolainen V.T., Penttila A., Karhumen P.J. Delayed increase in liver cirrhosis mortality and frequency of alcoholic liver cirrhosis following an increased and redistribution of alcohol consumption in Finland Evidence from mortality statistics and autopsy survey covering 8533 cases in 1968-1988 . Alcohol Clin Exp Res. 16:1992;661-664.
66. Pequignot G., Chabert C., Eydoux H., et al. Increased risk of liver cirrhosis with intake of alcohol. Rev Alcohol. 20:1974;191-202.
67. Lelbach W.K. Quantitative aspects of drinking in alcoholic liver cirrhosis. Khanna H.M., Israel Y., Kalant H. Alcoholic liver pathology. 1975;1-18 Toronto Addiction Research Foundation of Ontario, Toronto, Canada.
68. Rankin J.G., Schmidt W., Popham R.E., et al. Epidemiology of alcoholic liver disease - insights and problems. Kunna J.M., Israel Y., Kalant H. Alcoholic liver pathology. 1975;31-41 Alcoholism and Drug Addiction Research Foundation of Ontario, Toronto, Canada.
69. Sorensen T.I. Alcohol and liver injury. Dose-related or permissive effect? Liver. 9:1989;189-197.
70. Marbet U.A., Bianchi L., Maury U., Stalder G.A. Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease. J Hepatol. 4:1987;364-372.
71. Lindros K.O. Alcoholic liver disease Pathobiological aspects . J Hepatol. 23:(suppl):1995;7-15.
72. Bird G.L.A., Williams R. Factors determining cirrhosis in alcoholic liver disease. Mol Aspects Med. 10:1988;97-105.
73. Becker U., Deis A., Sorensen T.I.A., et al. Prediction of risk of liver disease by alcohol intake, sex and age A prospective population study . Hepatology. 23:1996;1025-1029.
74. Nanji A.A., French S.W. Dietary factors and alcoholic cirrhosis. Alcohol Clin Exp Res. 10:1986;271-273.
75. Matsuoka M., Zhang M., Tsukamoto H. Sensitization of hepatic lipocytes by high fat to stimulatory affects of Kupffer cell-derived factors Implication in alcoholic liver fibrogenesis . Hepatology. 11:1990;173-182.
76. Nanji A.A., Hossein Sadrzadeh S.M., Yang E.K., et al. Dietary saturated fatty acids A novel treatment for alcoholic liver disease . Gastroenterology. 109:1995;547-554.
77. Naveau S., Belda E., Barthelemy P., et al. Obesity Risk factor of alcoholic cirrhosis . Hepatology. 22:1995;246A.
78. Cloninger C.R., Bohman M., Sigvardsson S. Inheritance of alcohol abuse Cross-Fostering Analysis of adopted men . Arch Gen Psychiatry. 38:1981;861-868.
79. Sigvardsson S., Bohman M., Cloninger R. Replication of the Stockholm adoption study of alcoholism. Confirmatory Cross-Fostering Analysis. Arch Gen Psychiatry. 53:1996;681-687.
80. Lumeng L., Crabb D.W. Genetic aspects and risk factors in alcoholism and alcoholic liver disease. Gastroenterology. 107:1994;572-578.
81. Mendenhall C.L., Seeff L., Diehl A.M., et al. Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis Their prevalence and clinical relevance . Hepatology. 14:1991;581-589.
82. Koff R.S., Dienstag J.L. Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Semin Liver Dis. 15:1995;101-109.
83. Mendenhall C.L., Moritz T., Rouster S., et al. Epidemiology of hepatitis C among veterans with alcoholic liver disease. Am J Gastroenterol. 88:1993;1022-1026.
84. Caldwell S.H., Li X., Rourk R.M., et al. Hepatitis C infection by polymerase chain reaction in alcoholics False-positive ELISA results and the influence of infection on clinical prognostic score . Am J Gastroenterol. 88:1993;1016-1021.
85. Brillanti S., Magci C., Siringo S., et al. Serological and histological aspects of hepatitis C virus infection in alcoholic patients. J Hepatol. 13:1991;347-350.
86. Yokoyama H., Ishii H., Moriya S., et al. Relationship between hepatitis C virus subtypes and clinical features of liver disease seen in alcoholics. J Hepatol. 22:1995;130-134.
87. Nishiguchi S., Kiroki T., Yabusako T., et al. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Hepatology. 14:1991;985-989.
88. Pares A., Barrera J.M., Caballeria J., et al. Hepatitis C virus antibodies in chronic alcoholic patients Associations with severity of liver injury . Hepatology. 12:1990;1295-1299.
89. Corrao G., Carle F., Lepore A.R., et al. Interaction between alcohol consumption and positivity for antibodies to hepatitis C virus on the risk of liver cirrhosis A case control study . Eur J Epidemiol. 8:1992;634-639.
90. Takase S., Tsutsumi M., Kawahara H. The alcohol-altered liver membrane antibody and hepatitis C virus infection in the progression of alcoholic liver disease. Hepatology. 17:1993;9-13.
91. Yamauchi M., Nakahara M., Maezawa Y., et al. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C. Am J Gastroenterol. 88:1993;39-43.
92. Bassett M.L., Halliday J.N., Powell L.W. Value of hepatic iron measurement in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology. 6:1986;24-29.
93. Piperno A., D'Alb R., Fargio S., et al. Liver iron concentration in chronic viral hepatitis A study of 98 patients . Eur J Gastroenterol Hepatol. 7:1995;1203-1208.
94. Adams P.C., Agnew S. Alcoholism in hereditary hemochromatosis revisited Prevalence and clinical consequences among homozygous siblings . Hepatology. 23:1996;724-727.
95. Feder J.N., Gnirke A., Thomas W., et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet. 13:1996;399-408.
96. Bacon B.R. Diagnosis and management of hemochromatosis. Gastroenterology. 113:1997;995-999.
97. Gluud C., Henriksen J.H., Nielsen G. Prognostic indicators in alcoholic cirrhotic men. Hepatology. 8:1988;222-227.
98. MacSween R.N.M., Burt A.D. Histologic spectrum of alcoholic liver disease. Semin Liv Dis. 6:1986;121-132.
99. Orrego H., Blake J.E., Blendis L.M., et al. Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology. 92:1987;208-214.
100. Ohnishi K., Matsuo S., Matsutani K., et al. Interferon therapy for chronic hepatitis C in habitual drinkers Comparison with chronic hepatitis C in infrequent drinkers . Am J Gastroenterol. 91:1996;1274-1279.
101. Oshita M., Hayashi N., Kasahara A. Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C. Hepatology. 20:1994;115-120.
102. Powell J.H., Klatskin G. Duration of survival in Laennec's cirrhosis. Am J Med. 44:1968;406-420.
103. Kawasaki S., Henderson M., Hertzler G., et al. The role of continued drinking in loss of portal perfusion after distal splenorenal shunt. Gastroenterology. 100:1991;799-804.
104. Borowsky S.A., Strome S., Lott E. Continued heavy drinking and survival in alcoholic cirrhosis. Gastroenterology. 80:1981;1405-1409.
105. Dagradi A.E. The natural history of oesophageal varices in patients with alcoholic cirrhosis An endoscopic and clinical study . Am J Gastroenterol. 57:1972;520-540.
106. McCormick P.A., Morgan M.Y., Phillips A., et al. The effects of alcohol use on rebleeding and mortality in patients with alcoholic cirrhosis following variceal hemorrhage. J Hepatol. 14:1992;99-103.
107. McCullough A.J., Tavill A.S. Disordered protein and energy metabolism in liver disease. Semin Liv Dis. 11:1991;265-277.
108. McCullough A.J., Bugianesi E. Protein-calorie malnutrition and the etiology of cirrhosis. Am J Gastroenterol. 92:1997;734-738.
109. Caregaro L., Alberino F., Amodio P., et al. Malnutrition in alcoholic and virus-related cirrhosis. Am J Clin Nutr. 63:1996;602-609.
110. Nompleggi D.J., Bonkovsky H.L. Nutritional supplementation in chronic liver disease An analytical review . Hepatology. 19:1994;518-533.
111. Cabre E., Gonzales-Huiz F., Abad-LaCruz A., et al. Effect of total enteral nutrition on the short term outcome of severely malnourished cirrhotics. Gastroenterol. 98:1990;715-720.
112. Kearns P.J., Young H., Garcia G., et al. Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology. 102:1992;200-205.
113. Reilly J., Mehta R., Teperman L., et al. Nutritional support after liver transplantation A randomized prospective study . JPEN. 14:1990;386-391.
114. Marchesini G., Dioguardo F.S., Bianchi G.P., et al. Long term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. J Hepatol. 11:1990;92-101.
115. Hirsch S., Bunout D., DeLamaza P., et al. Controlled trial of nutrition supplementation in outpatients with symptomatic alcoholic cirrhosis. JPEN. 17:1993;119-124.
116. Fabbri A., Magrini N., Bianchi G. Overview of randomized clinical trials of oral branched-chain amino acid treatment in chronic hepatic encephalopathy. JPEN. 20:1996;159-164.
117. Swart G.R., Zillikens M.C., VanVuure J.K., et al. Effect of late evening meal on nitrogen balance in patients with cirrhosis of the liver. Br Med J. 299:1989;1202-1203.
118. Zillikens M.C., Vandenberg J.W.O., Wahimena J.L.D., et al. Nocturnal oral glucose supplementation. J Hepatol. 17:1993;377-383.
119. Van de Venne W.P.H.G., Westerterp K.R., VanHoek A. Habitual pattern of food intake in patients with liver disease. Clin Nutr. 12:1993;293-297.
120. Kondrup J., Müller M.J. Energy and protein requirements of patients with chronic liver disease. J Hepatol. 27:1997;239-247.
121. McCullough AJ, Teran JC, Bugianesi E. Guidelines for nutritional therapy in liver disease. In: Klein S, ed. The ASPEN Nutrition Support Practice Manual. 1998:1-12.
122. Campillo B., Bories P.N., Leluen M. Short term changes in energy metabolism after 1 month of a regular oral diet in severely malnourished cirrhotic patients. Metabolism. 44:1995;765-770.
123. Nielson K., Kondrup J., Martinsen R. Long term oral feeding of patients with cirrhosis of the liver. Br J Nutr. 74:1995;557-567.
124. Nielson K., Kondrup J., Martinsen L., et al. Nutritional assessment and adequacy of dietary intake in hospitalized patients with alcoholic cirrhosis. Br J Nutr. 69:1993;665-679.
125. Iturriaga H., Ugarte G., Israel Y. Hepatic vein oxygenation, liver blood flow and the rate of ethanol metabolism in recently abstinent alcoholic patients. Eur J Clin Invest. 10:1980;211-218.
126. Hadengue A., Moreau R., Lee S.S., et al. Liver hypermetabolism during alcohol withdrawal in humans. Gastroenterology. 94:1988;1047-1052.
127. Kessler B.J., Liebler J.B., Bronfing J., et al. The hepatic blood flow and splanchnic oxygen consumption in alcoholic fatty liver. J Clin Invest. 33:1954;1338-1345.
128. Hayashi N., Kasahara A., Kurosawa K., et al. Oxygen supply to the liver in patients with alcoholic liver disease assessed by organ-reflectance spectrophotometry. Gastroenterology. 88:1985;881-886.
129. Kasahara A., Hayashi N., Sasaki Y., et al. Hepatic circulation and hepatic oxygen consumption in alcoholic and non alcoholic fatty liver. Am J Gastroenterol. 83:1988;846-849.
130. Orrego H., Blake J.E., Blendis L.M., et al. Long-term treatment of alcoholic liver disease with propylthiouracil. N Engl J Med. 317:1987;1421-1427.
131. Orrego H., Blake J.E., Blendis L.M. Long term treatment of alcoholic liver disease with propylthiouracil. Part 2: Influence of drop out rates and of continued alcoholic consumption in a clinical trial . J Hepatol. 20:1994;343-349.
132. Kershenobich D., Vargas F., Garcia-Tsao G., et al. Colchicine in the treatment of cirrhosis of the liver. N Engl J Med. 318:1988;1709-1713.
133. Akriviadis E.A., Steindel H., Pinto P.C., et al. Failure of colchicine to improve short-term survival in patients with alcoholic hepatitis. Gastroenterology. 99:1990;811-818.
134. Sherman D., Williams R. Liver transplantation for alcoholic liver disease. J Hepatol. 23:1995;474-479.
135. Hoofnagle J.H., Kresina T., Fuller R.K., et al. Liver transplantation for alcoholic liver disease Executive statement and recommendations . Liver Transplant Surg. 3:1997;3347-3348.
136. Belle S.H., Beringer K.C., Detre K.M. Liver transplantation for alcoholic liver disease in the United States 1988-1995 . Liver Transplant Surg. 3:1997;212-219.
137. Krom R.A.F. Liver transplantation and alcohol Who should get transplants? Hepatology. 20:1994;28S-32S.
138. Bird G.L., O'Grady J.G., Harvey F.A., et al. Liver transplantation in patients with alcoholic cirrhosis Selection criteria and rates of survival and relapse . Br Med J. 301:1990;15-17.
139. Lucey M.R., Merion R.M., Henley K.S., et al. Selection for and outcome of liver transplantation in alcoholic liver disease. Gastroenterology. 102:1992;1736-1741.
140. Gish R.G., Lee A.H., Keeffe E.B. Liver transplantation for patients with alcoholism and end-stage liver disease. Am J Gastroenterol. 88:1993;1337-1342.
141. Kumar S., Stauber R.E., Gavaler J.S., et al. Orthotopic liver transplantation for alcoholic liver disease. Hepatology. 11:1990;159-164.
142. Pereira S.P., Williams R. Liver transplantation for alcoholic liver disease at King's College Hospital Survival and quality of life . Liver Transplant Surg. 3:1997;245-250.
143. Weisner R.H., Lombardero M., Lake J.R. Liver transplantation for end-stage alcoholic liver disease An assessment of outcomes . Liver Transplant Surg. 3:1997;231-239.
144. Poynard T., Barthelemy P., Fratte S., et al. Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls. Lancet. 344:1994;502-507.
145. Beresford T.P., Schwartz J., Wilson D., et al. The short-term psychological health of alcoholic and non-alcoholic liver transplant recipients. Alcohol Clin Exp Res. 16:1992;996-1000.
146. Berlakovich G.A., Steininger R., Herbst F., et al. Efficacy of liver transplantation for alcoholic cirrhosis with respect to recidivism and compliance. Transplantation. 58:1994;560-565.
147. Osorio R.W., Ascher N.L., Avery M., et al. Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology. 20:1994;105-110.
148. Knechtle S.J., Fleming M.F., Barry K.L., et al. Liver transplantation for alcoholic liver disease. Surgery. 112:1992;694-703.
149. Goldstein R., Tripp L., Clemmons J., et al. Liver transplantation for alcoholic cirrhosis - do they mix? Transplant Proc. 25:1993;1131-1132.
150. Lucey M.R. Issues in selection for and outcome of liver transplantation in patients with alcoholic liver disease. Liver Transplant Surg. 3:1997;227-230.
151. Lucey M.R., Carr K., Beresford T.P., et al. Alcohol use after liver transplantation in alcoholics A clinical cohort follow-up study . Hepatology. 25:1997;1223-1227.
152. Beresford T.P. Psychiatric follow-up care of alcohol-dependent liver graft recipients. Lucey M.R., Merion R.M., Beresford T.P. Liver Transplantation and the Alcoholic Patient. 1994;96-112 Cambridge University Press, New York.
153. Everhard J.E., Beresford T.P. Liver transplantation for alcoholic liver disease A survey of transplantation programs in the United States . Liver Transplant Surg. 3:1997;220-226.
154. Keeffe E.B. Comorbidities of alcoholic liver disease that affect outcome of orthotopic liver transplantation. Liver Transplant Surg. 3:1997;251-257.
155. Pugh R.N.H., Murray-Lyon I.M., Dawson J.L., et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 60:1973;646-648.
156. Orrego Y., Israel Y., Blake J.E., et al. Assessment of prognostic factors in alcoholic liver disease Toward a global quantitative expression of severity . Hepatology. 3:1983;896-905.
157. Maddrey W.C. Alcoholic hepatitis Clinicopathologic features and therapy . Semin Liver Dis. 8:1988;91-102.
158. Mendenhall C.L. Alcoholic hepatitis. Schiff L., Schiff E.R. Diseases of the Liver. Sixth Edition :1987;669-685 J.B. Lippincott, Philadelphia.
159. Helman R.A., Temko M.H., Nye S.W., et al. Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy. Ann Intern Med. 1971;311-321.
160. Lesesne H.R., Buzymski E.M., Fallon H.G. Treatment of alcoholic hepatitis with encephalopathy. Comparison of prednisolone with caloric supplements. Gastroenterology. 74:1978;169-173.
161. Maddrey W.C., Boitnott J.K., Bedine M., et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 75:1978;193-199.
162. Ramond M.J., Poynard T., Rueff B., et al. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med. 326:1992;507-512.
163. Carithers R.L., Herlong F., Diehl A.M., et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. Ann Intern Med. 110:1989;685-690.
164. Mendenhall C.L., Anderson S., Garcia-Pont P. Short term and long term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med. 311:1984;1464-1470.
165. Theodossi A., Eddleston A.L.W.F., Williams R. Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis. Gut. 23:1982;75-79.
166. Depew W., Boyer T., Omata M., et al. Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy. Gastroenterology. 78:1980;524-529.
167. Shumaker J.B., Resnick R.H., Galambos J.T., et al. A controlled trial of methylprednisolone in acute alcoholic hepatitis. Am J Gastroenterol. 69:1978;443-449.
168. Blitzer B.L., Mutchnik M.G., Joshi P.H., et al. Adrenocorticosteroid therapy in alcoholic hepatitis. Dig Diseases. 22:1977;477-484.
169. Campra J.L., Hamlin E.M., Kirshbaum R.J., et al. Prednisone therapy of acute alcoholic hepatitis. Ann Intern Med. 79:1973;625-631.
170. Porter H.P., Simon F.R., Pope C.E., et al. Corticosteroid therapy in severe alcoholic hepatitis. N Engl J Med. 284:1971;1250-1255.
171. Reynolds T.B., Benhamou J.P., Blake J., et al. Treatment of acute alcoholic hepatitis. Gastroenterol Int. 2:1989;208-216.
172. Christensen E., Glund C. Glucocorticoids are ineffective in alcoholic hepatitis A meta-analysis adjusting for confounding variables . Gut. 37:1995;113-118.
173. Schichting P., Juhl E., Poulsen H., et al. Alcoholic hepatitis superimposed on cirrhosis, clinical significance of long term prednisone treatment. Scand J Gastroenterol. 22:1976;305-312.
174. Uribe M., Schalm S.W., Summerskill W.H.J., et al. Oral prednisone for chronic active liver disease dose response and bioavailability studies . Gut. 19:1978;1131-1135.
175. Mendenhall C.L., Anderson S., Weesner R.E., et al. Protein calorie malnutrition associated with alcoholic hepatitis. Am J Med. 76:1984;211-222.
176. Soberon S., Pauley M.P., Duplantier R., et al. Metabolic effects of enteral formula feeding in alcoholic hepatitis. Hepatology. 7:1987;1204-1209.
177. Bonkovsky H.L., Fiellin D.A., Smith G.S., et al. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function. Am J Gastroenterol. 86:1991;1200-1208.
178. Mezey E., Caballeria J., Mitchell M., et al. Effects of parenteral amino acid supplementation on short term and long term outcomes in severe alcoholic hepatitis A randomized controlled trial . Hepatology. 14:1991;1090-1096.
179. Achord J.L. A prospective randomized clinical trial of peripheral amino acid-glucose supplementation in acute alcoholic hepatitis. Am J Gastroenterol. 82:1987;871-875.
180. Simon D., Galambos J.T. A randomized controlled study of peripheral parenteral nutrition in moderate and severe alcoholic hepatitis. J Hepatol. 7:1988;200-207.
181. Diehl A.M., Boitnott J.K., Herlong H.F., et al. Effect of parenteral amino acid supplementation in alcoholic hepatitis. Hepatology. 5:1985;57-63.
182. Nasrallah S.M., Galambos J.T. Amino acid therapy of alcoholic hepatitis. Lancet. ii:1980;1275-1279.
183. Naveau S., Pelletier G., Poynard T., et al. A randomized clinical trial of supplementary parenteral nutrition in jaundiced alcoholic cirrhotic patients. Hepatology. 6:1986;270-274.
184. Calvey H., Davis M., Williams M. Controlled trial of nutritional supplementation with and without branched chain amino acid enrichment in treatment of acute alcoholic hepatitis. J Hepatol. 1:1985;141-151.
185. Koretz R.L. Nutritional support in alcoholic liver disease. Gastroenterology. 102:1992;2186-2187.
186. Souba W.W. Nutritional support. N Engl Med. 336:1996;41-48.
187. Horst D., Grace N.D., Conn H.O., et al. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy A randomized trial . Hepatology. 4:1984;279-287.
188. Naylor C.D., O'Rouke K., Detsky A.S., et al. Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterology. 97:1989;1033-1042.
189. Mendenhall C.L., Moritz T.E., Roselle G.A., et al. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis Results of a Department of Veterans Affairs Cooperative Study . Hepatology. 17:1993;564-576.
190. Hoffman A.L., Rosen H.R., Ljubimova J.A., et al. Hepatic regeneration. Semin Liver Dis. 14:1994;190-210.
191. Baker A.L., Jaspan J.B., Haines N.W., et al. A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis Progress report in 50 patients . Gastroenterology. 80:1981;1410-1414.
192. Feher J., Cornides A., Romany A., et al. A prospective multicenter study of insulin and glucagon infusion therapy in acute alcoholic hepatitis. J Hepatol. 5:1997;224-231.
193. Trinchet J.C., Balkau B., Poupon R.E., et al. Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon A multicenter sequential trial . Hepatology. 15:1992;76-81.
194. Bird G., Lau J.Y.N., Koskinas J., et al. Insulin and glucagon infusion in acute alcoholic liver disease A prospective randomized controlled trial . Hepatology. 14:1991;1097-1101.
195. Radvan G., Kanel G., Redeker A. Insulin and glucagon infusion in acute alcoholic hepatitis. Gastroenterology. 82:1982;A1154.
196. Takada A., Nei J., Tamino H., et al. Effects of malotilate on ethanol-inhibited hepatocyte regeneration in rats. J Hepatol. 5:1987;336-343.
197. Keiding S., Badsberg J.H., Becker U., et al. The prognosis of patients with alcoholic liver disease. An international randomized placebo-controlled trial on the effects of malotilate on survival. J Hepatol. 20:1994;454-460.
198. Valarini R., Sousa M.F., Kalil R., et al. Anabolic effects of insulin and amino acids in promoting nitrogen accretion in postoperative patients. JPEN. 18:1994;214-218.
199. Orrego H., Kalant H., Israel Y., et al. Effect of short term therapy with PTU in patients with alcoholic liver disease. Gastroenterology. 76:1979;105-115.
200. Halle P., Pare P., Kaptein E., et al. Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis. Gastroenterology. 87:1982;925-931.
201. Israel Y., Walfish P.G., Orrego H., et al. Thyroid hormones in alcoholic liver disease. Effect of treatment with 6-n-propylthiouracil. Gastroenterology. 76:1979;116-122.
202. Galambos J.T. Natural history of alcoholic hepatitis III. Histological changes. Gastroenterology. 63:1972;1026-1035.
203. Neuberger J., Bryan S. Clinical economics review Cost-effectiveness in the therapy of liver disease . Aliment Pharmacol Exp Ther. 11:1997;61-68.
204. Weinrieb R.M., O'Brien C.P. Current research in the treatment of alcoholism in liver transplant recipients. Liver Transplant Surg. 3:1997;332-336.
205. Benjamin M. Transplantation for alcoholic liver disease The ethical issues . Liver Transplant Surg. 3:1997;337-342.
206. Ubel P.A. Transplantation in alcoholics Separating prognosis and responsibility from social biases . Liver Transplant Surg. 3:1997;343-346.